18F-FDG PET/CT
Bone
Sarcoidosis
Journal
Clinical rheumatology
ISSN: 1434-9949
Titre abrégé: Clin Rheumatol
Pays: Germany
ID NLM: 8211469
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
19
12
2019
accepted:
28
02
2020
revised:
30
01
2020
pubmed:
22
3
2020
medline:
15
5
2021
entrez:
22
3
2020
Statut:
ppublish
Résumé
Bone sarcoidosis is usually rare. Imaging procedures such as fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography ( This was an observational retrospective study of individuals with pulmonary sarcoidosis who underwent Data for 85 patients with sarcoidosis (56.5% female, median age 47 [range 21-80] years) were analyzed. The median follow-up was 4 years. Among 56 patients, sarcoidosis occurred in more than three organs. According to ATS/ERS/WASOG criteria, bone sarcoidosis was diagnosed in 12 (14%) patients. The spine was the most commonly affected location (92%, n = 11), followed by the pelvis (67%, n = 8), sternum (33%, n = 4), humerus (25%, n = 3), and fingers (17%, n = 2). Only peripheral adenopathy was associated with bone sarcoidosis (p = 0.04). Seven patients had a Bone sarcoidosis occurred in 14% of patients with sarcoidosis, affecting multiple bones and mostly the axial skeleton.
Identifiants
pubmed: 32198555
doi: 10.1007/s10067-020-05022-6
pii: 10.1007/s10067-020-05022-6
doi:
Substances chimiques
Radiopharmaceuticals
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
2727-2734Références
Lefere M, Larbi A, Malghem J, Berg BV, Dallaudière B (2014) Vertebral sarcoidosis: long-term follow-up with MRI. Skelet Radiol 43:1185–1190. https://doi.org/10.1007/s00256-014-1870-1
doi: 10.1007/s00256-014-1870-1
Bechman K, Christidis D, Walsh S, Birring SS, Galloway J (2018) A review of the musculoskeletal manifestations of sarcoidosis. Rheumatology (Oxford) 57:777–783. https://doi.org/10.1093/rheumatology/kex317
doi: 10.1093/rheumatology/kex317
Thelier N, Assous N, Job-Deslandre C, Meyer O, Bardin T, Orcel P, Lioté F, Dougados M, Kahan A, Allanore Y (2008) Osteoarticular involvement in a series of 100 patients with sarcoidosis referred to rheumatology departments. J Rheumatol 35:1622–1628
pubmed: 18634144
Conte G, Zugni F, Colleoni M, Renne G, Bellomi M, Petralia G (2015) Sarcoidosis with bone involvement mimicking metastatic disease at 18F-FDG PET/CT: problem solving by diffusion whole-body MRI. Ecancermedicalscience 9. https://doi.org/10.3332/ecancer.2015.537
Sparks JA, McSparron JI, Shah N, Aliabadi P, Paulson V, Fanta CH, Coblyn JS (2014) Osseous sarcoidosis: clinical characteristics, treatment, and outcomes—experience from a large, academic hospital. Semin Arthritis Rheum 44:371–379. https://doi.org/10.1016/j.semarthrit.2014.07.003
doi: 10.1016/j.semarthrit.2014.07.003
pubmed: 25129260
Wilcox A, Bharadwaj P, Sharma OP (2000) Bone sarcoidosis. Curr Opin Rheumatol 12:321
doi: 10.1097/00002281-200007000-00016
Zhou Y, Lower EE, Li H, Farhey Y, Baughman RP (2017) Clinical characteristics of patients with bone sarcoidosis. Semin Arthritis Rheum 47. https://doi.org/10.1016/j.semarthrit.2017.02.004
Glaudemans AWJM, Vries D, Filippo JE, Galli F, Dierckx RAJO, Slart RHJA et al (2013) The use of F-FDG-PET/CT for diagnosis and treatment monitoring of inflammatory and infectious diseases. J Immunol Res. https://doi.org/10.1155/2013/623036
Aberg C, Ponzo F, Raphael B, Amorosi E, Moran V, Kramer E (2004) FDG positron emission tomography of bone involvement in sarcoidosis. AJR Am J Roentgenol 182:975–977. https://doi.org/10.2214/ajr.182.4.1820975
doi: 10.2214/ajr.182.4.1820975
pubmed: 15039174
Baldini S, Pupi A, Di Lollo S, Marchionni N, Shraim R, Bosi A (2008) PET positivity with bone marrow biopsy revealing sarcoidosis in a patient in whom bone marrow metastases had been suspected. Br J Haematol 143:306. https://doi.org/10.1111/j.1365-2141.2008.07288.x
doi: 10.1111/j.1365-2141.2008.07288.x
pubmed: 18671698
Clarençon F, Silbermann-Hoffman O, Lebreton C, Fernandez P, Kerrou K, Marchand-Adam S, Hourseau M, Schouman-Claeys E, Feydy A (2007) Diffuse spine involvement in sarcoidosis with sternal lytic lesions: two case reports. Spine 32:E594–E597. https://doi.org/10.1097/BRS.0b013e31814b86d5
doi: 10.1097/BRS.0b013e31814b86d5
pubmed: 17873802
Grozdic Milojevic I, Sobic-Saranovic D, Videnovic-Ivanov J, Saranovic D, Odalovic S, Artiko V (2016) FDG PET/CT in bone sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 33:66–74
pubmed: 27055838
Kaira K, Oriuchi N, Otani Y, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Endo K, Mori M (2007) Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients. Chest 131:1019–1027. https://doi.org/10.1378/chest.06-2160
doi: 10.1378/chest.06-2160
pubmed: 17426205
Ludwig V, Fordice S, Lamar R, Martin WH, Delbeke D (2003) Unsuspected skeletal sarcoidosis mimicking metastatic disease on FDG positron emission tomography and bone scintigraphy. Clin Nucl Med 28:176–179. https://doi.org/10.1097/01.RLU.0000053528.35645.70
doi: 10.1097/01.RLU.0000053528.35645.70
pubmed: 12592122
Mostard RL, Prompers L, Weijers RE, van Kroonenburgh MJ, Wijnen PA, Geusens PP, Drent M (2012) F-18 FDG PET/CT for detecting bone and bone marrow involvement in sarcoidosis patients. Clin Nucl Med 37:21–25. https://doi.org/10.1097/RLU.0b013e3182335f9b
doi: 10.1097/RLU.0b013e3182335f9b
pubmed: 22157023
de Prost N, Kerrou K, Sibony M, Talbot J-N, Wislez M, Cadranel J (2010) Fluorine-18 Fluorodeoxyglucose with positron emission tomography revealed bone marrow involvement in Sarcoidosis patients with Anaemia. RES 79:25–31. https://doi.org/10.1159/000204901
doi: 10.1159/000204901
Costabel U, Hunninghake GW (1999) ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis statement committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur Respir J 14:735–737
doi: 10.1034/j.1399-3003.1999.14d02.x
Judson MA, Costabel U, Drent M, Wells A, Maier L, Koth L et al (2014) The WASOG Sarcoidosis organ assessment instrument: an update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis 31:19–27
James DG, Neville E, Siltzbach LE (1976) A worldwide review of sarcoidosis. Ann N Y Acad Sci 278:321–334
doi: 10.1111/j.1749-6632.1976.tb47043.x
Zisman DA, Shorr AF, Lynch JP (2002) Sarcoidosis involving the musculoskeletal system. Semin Respir Crit Care Med 23:555–570. https://doi.org/10.1055/s-2002-36520
doi: 10.1055/s-2002-36520
pubmed: 16088651